Dasatinib in Combination With Revlimid (and Dexamethasone)

Mise à jour : Il y a 4 ans
Référence : NCT00560391

Femme et Homme

Extrait

The purpose of this study was to determine the safety and tolerability of dasatinib when given in combination with lenalidomide and a low dose dexamethasone for the treatment of relapsed or refractory multiple myeloma.


Critère d'inclusion

  • Multiple myeloma

Liens